119 related articles for article (PubMed ID: 23686365)
1. Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.
Yao S; Zhang J; Chen H; Sheng Y; Zhang X; Liu Z; Zhang C
J Histochem Cytochem; 2013 Sep; 61(9):639-48. PubMed ID: 23686365
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of biomarkers of hepatocellular carcinoma.
Mohammed AF; Chen X; Li C
Bratisl Lek Listy; 2024; 125(2):102-106. PubMed ID: 38219063
[TBL] [Abstract][Full Text] [Related]
3. Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma.
Shirakawa H; Suzuki H; Shimomura M; Kojima M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
Cancer Sci; 2009 Aug; 100(8):1403-7. PubMed ID: 19496787
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3 is overexpressed in human hepatocellular carcinoma.
Sung YK; Hwang SY; Park MK; Farooq M; Han IS; Bae HI; Kim JC; Kim M
Cancer Sci; 2003 Mar; 94(3):259-62. PubMed ID: 12824919
[TBL] [Abstract][Full Text] [Related]
5. Glypican-3-targeted precision diagnosis of hepatocellular carcinoma on clinical sections with a supramolecular 2D imaging probe.
Han HH; Qiu YJ; Shi YY; Wen W; He XP; Dong LW; Tan YX; Long YT; Tian H; Wang HY
Theranostics; 2018; 8(12):3268-3274. PubMed ID: 29930728
[TBL] [Abstract][Full Text] [Related]
6. Expression of glypican-3, SALL4, and CD34 in undifferentiated endometrial carcinomas.
Kihara A; Amano Y; Arai Y; Fujiwara H; Niki T
Pathology; 2024 Jun; 56(4):591-594. PubMed ID: 37872019
[No Abstract] [Full Text] [Related]
7. Frozen section in borderline ovarian tumors: is it reliable?
Ureyen I; Turan T; Cirik DA; Tasci T; Boran N; Bulbul D; Tulunay G
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():115-8. PubMed ID: 25145763
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of the reticulin stain in the differential diagnosis of liver nodules on fine-needle aspiration biopsy cell block preparations.
Bergman S; Graeme-Cook F; Pitman MB
Mod Pathol; 1997 Dec; 10(12):1258-64. PubMed ID: 9436973
[TBL] [Abstract][Full Text] [Related]
9. GPC3 gene expression and allelic discrimination of FZD7 gene in Egyptian patients with hepatocellular carcinoma.
Ramadan A; Ghanem HM; Mohamed AA; Elshobaky M; El Agawy W; Gawad EAHA; Eldeeb HH; Ezz Al Arab MR; Kamal MM
Rep Pract Oncol Radiother; 2023; 28(4):485-495. PubMed ID: 37795234
[TBL] [Abstract][Full Text] [Related]
10. Interpretation of Farnesoid X Receptor Immunohistochemical Expression in Discriminating Hepatocellular Carcinoma from Its Non-Neoplastic Mimics as an Adjunct to Glypican 3.
Salama DEA; Shash LS; Shakweer MM; Abdel-Maqsoud RR; Ahmed Abosaif AI; Elgohary SA
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3221-3227. PubMed ID: 37774075
[TBL] [Abstract][Full Text] [Related]
11. Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma.
Zheng X; Liu X; Lei Y; Wang G; Liu M
Front Oncol; 2022; 12():824208. PubMed ID: 35251989
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Wang C; Shao X; Zhang X; Xie C; Yu J; Xu X; Yang J; Li Y; Xu W
Transl Cancer Res; 2020 Jan; 9(1):128-136. PubMed ID: 35117166
[TBL] [Abstract][Full Text] [Related]
13. The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma.
Su D
Bioengineered; 2021 Dec; 12(2):11124-11135. PubMed ID: 34923912
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of a
Kerdput V; Nilbu-Nga C; Kaewnoonual N; Itharat A; Pongsawat S; Pradidarcheep W
J Tradit Complement Med; 2021 Sep; 11(5):400-408. PubMed ID: 34522634
[TBL] [Abstract][Full Text] [Related]
15. Correlation of radiomic features on dynamic contrast-enhanced magnetic resonance with microvessel density in hepatocellular carcinoma based on different models.
Liang H; Hu C; Lu J; Zhang T; Jiang J; Ding D; Du S; Duan S
J Int Med Res; 2021 Mar; 49(3):300060521997586. PubMed ID: 33682491
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis.
Tao P; Gao L; Li H; Wang B; Li X; Zhang Y; Chen H
Medicine (Baltimore); 2020 Dec; 99(52):e23841. PubMed ID: 33350772
[TBL] [Abstract][Full Text] [Related]
17. Golgi protein 73, hepatocellular carcinoma and other types of cancers.
Wang Y; Wan YY
Liver Res; 2020 Dec; 4(4):161-167. PubMed ID: 33343966
[TBL] [Abstract][Full Text] [Related]
18. Combination of biomarkers for the detection of hepatocellular carcinoma.
Sternby Eilard M; Åberg F
Ann Transl Med; 2020 Oct; 8(20):1283. PubMed ID: 33209863
[No Abstract] [Full Text] [Related]
19. Complement factor H-deficient mice develop spontaneous hepatic tumors.
Laskowski J; Renner B; Pickering MC; Serkova NJ; Smith-Jones PM; Clambey ET; Nemenoff RA; Thurman JM
J Clin Invest; 2020 Aug; 130(8):4039-4054. PubMed ID: 32369457
[TBL] [Abstract][Full Text] [Related]
20. Muscle metabolomics analysis reveals potential biomarkers of exercise‑dependent improvement of the diaphragm function in chronic obstructive pulmonary disease.
Li J; Lu Y; Li N; Li P; Su J; Wang Z; Wang T; Yang Z; Yang Y; Chen H; Xiao L; Duan H; Wu W; Liu X
Int J Mol Med; 2020 Jun; 45(6):1644-1660. PubMed ID: 32186768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
